ARC Medical

ARC Medical is a clinical-stage biotechnology company headquartered in Vancouver, Canada, specializing in the prevention of post-surgical adhesions. The company's core technology involves the use of recombinant human Proteoglycan 4 (rhPRG4), also known as lubricin, a glycoprotein that naturally occurs in human synovial fluid to provide lubrication and prevent tissue-to-tissue attachment. ARC Medical's lead product candidate, JOI-001, is being developed to reduce internal scarring and improve functional recovery following orthopedic surgeries, such as tendon repairs. By leveraging the anti-adhesive and anti-inflammatory properties of lubricin, the company aims to address a significant unmet need in surgical recovery across various medical specialties, including orthopedic, abdominal, and pelvic procedures.